Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/rassf1a-polymorphism-in-familial-breast-cancer-joDWtkGowi
References (12)
-
M. Fackler, M. McVeigh, E. Evron, E. Garrett, J. Mehrotra, K. Polyak, S. Sukumar, P. Argani (2003)
DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinomaInternational Journal of Cancer, 107
-
Don Conroy, M. Shah, H. Munday, C. Jordan, B. Perkins, Judy West, Karen Redman, K. Driver, Morteza Aghmesheh, D. Amor, Lesley Andrews, Y. Antill, Jane Armes, Shane Armitage, Leanne Arnold, Rosemary Balleine, Glenn Begley, J. Beilby, Ian Bennett, Barbara Bennett, Geoffrey Berry, Anneke Blackburn, Meagan Brennan, Melissa Brown, Michael Buckley, J. Burke, Phyllis Butow, Keith Byron, David Callen, Ian Campbell, G. Chenevix-Trench, Christine Clarke, Alison Colley, Dick Cotton, Jisheng Cui, Bronwyn Culling, Margaret Cummings, Sarah-Jane Dawson, Joanne Dixon, Alexander Dobrovic, Tracy Dudding, Ted Edkins, M. Eisenbruch, G. Farshid, Susan Fawcett, Michael Field, Frank Firgaira, Jean Fleming, John Forbes, Michael Friedlander, Clara Gaff, Mac Gardner, M. Gattas, Peter George, G. Giles, G. Gill, Jack Goldblatt, Sian Greening, S. Grist, Eric Haan, Marion Harris, Stewart Hart, N. Hayward, J. Hopper, Evelyn Humphrey, Mark Jenkins, Alison Jones, R. Kefford, Judy Kirk, James Kollias, Sergey Kovalenko, Sunil Lakhani, Jennifer Leary, Jacqueline Lim, Geoff Lindeman, Lara Lipton, Lizz Lobb, Mariette Maclurcan, Graham Mann, Deb Marsh, M. Mccredie, Michael McKay, Sue-Anne McLachlan, Bettina Meiser, R. Milne, Gillian Mitchell, Beth Newman, Imelda O’Loughlin, Lester Peters, K. Phillips, Melanie Price, Jeanne Reeve, Tony Reeve, Gina Rinehart, Bridget Robinson, Elizabeth Salisbury, J. Sambrook, Christobel Saunders, C. Scott, Elizabeth Scott, Rodney Scott, Andrew Shelling, M. Southey, A. Spurdle, Graeme Suthers, Donna Taylor, Christopher Tennant, Heather Thorne, S. Townshend, Kathy Tucker, Janet Tyler, Deon Venter, J. Visvader, Ian Walpole, Robin Ward, Paul Waring, Bev Warner, Graham Warren, Elizabeth Watson, Rachael Williams, Judy Wilson, Ingrid Winship, Adele Green, D. Gertig, Penny Webb (2007)
Genome-wide association study identifies novel breast cancer susceptibility lociNature, 447
-
H. Donninger, M. Vos, G. Clark (2007)
The RASSF1A tumor suppressorJournal of Cell Science, 120
-
D. Hunter, P. Kraft, K. Jacobs, D. Cox, M. Yeager, S. Hankinson, S. Wacholder, Zhaoming Wang, R. Welch, A. Hutchinson, Junwen Wang, Kai Yu, N. Chatterjee, N. Orr, W. Willett, G. Colditz, R. Ziegler, C. Berg, S. Buys, C. McCarty, H. Feigelson, E. Calle, M. Thun, R. Hayes, M. Tucker, D. Gerhard, J. Fraumeni, R. Hoover, G. Thomas, S. Chanock (2007)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 39
-
U. Schagdarsurengin, C. Seidel, E. Ulbrich, H. Kölbl, J. Dittmer, R. Dammann (2005)
A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast.International journal of oncology, 27 1
-
D. Evans, D. Eccles, N. Rahman, K. Young, M. Bulman, E. Amir, A. Shenton, A. Howell, F. Lalloo (2004)
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPROJournal of Medical Genetics, 41
-
F. Lalloo, D. Evans (2012)
Familial Breast CancerClinical Genetics, 82
-
A. Latif, K. Hadfield, S. Roberts, A. Shenton, F. Lalloo, G. Black, A. Howell, D. Evans, W. Newman (2009)
Breast cancer susceptibility variants alter risks in familial diseaseJournal of Medical Genetics, 47
-
J. Ioannidis (2008)
Why Most Discovered True Associations Are InflatedEpidemiology, 19
-
A. Antoniou, Rachel Hardy, L. Walker, D. Evans, A. Shenton, R. Eeles, S. Shanley, G. Pichert, L. Izatt, S. Rose, F. Douglas, D. Eccles, Patrick Morrison, J. Scott, R. Zimmern, D. Easton, Paul Pharoah (2008)
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsJournal of Medical Genetics, 45
-
R. Dammann, U. Schagdarsurengin, C. Seidel, M. Strunnikova, M. Rastetter, K. Baier, G. Pfeifer (2005)
The tumor suppressor RASSF1A in human carcinogenesis: an update.Histology and histopathology, 20 2
-
B. Gao, Xian-Jin Xie, Chunxian Huang, D. Shames, T. Chen, C. Lewis, A. Bian, Bifeng Zhang, O. Olopade, J. Garber, D. Euhus, G. Tomlinson, J. Minna (2008)
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.Cancer research, 68 1
- Publisher
- Springer Journals
- Copyright
- Copyright © 2010 by Springer Science+Business Media B.V.
- Subject
- Biomedicine; Biomedicine general; Epidemiology; Human Genetics ; Cancer Research
- ISSN
- 1389-9600
- eISSN
- 1573-7292
- DOI
- 10.1007/s10689-010-9335-8
- pmid
- 20361264
- Publisher site
- See Article on Publisher Site
Abstract
Inactivation or loss of the tumour suppressor Ras associated domain family 1 isoform A (RASSF1A) allele has been described in breast cancer. Recently, a missense polymorphism predicting p.A331S in RASSF1A was associated with an increased risk of breast cancer and early-onset breast cancer in BRCA1 and BRCA2 mutation carriers. We genotyped p.A331S RASSF1A in 854 independent, familial, white breast cancer patients (645 BRCA mutation negative, 119 BRCA1 and 90 BRCA2 positive) and compared the genotype in 331 healthy women. The RASSF1A p.A331S variant was not more common in the familial breast cancer cases than in the controls (P = 0.27). Subset analysis demonstrated no association in the BRCA1 (P = 0.26), BRCA2 (P = 0.16) or BRCA negative (P = 0.30) samples. Hence, the RASSF1A p.A331S polymorphism is not confirmed as a significant germline contributor to familial breast cancer susceptibility.
Journal
Familial Cancer – Springer Journals
Published: Apr 2, 2010